Clinical Study | Office of Clinical Research

Study To Evaluate The Effectiveness And Safety Of Ocrelizumab In Participants With Early Stage Relapsing Remitting Multiple Sclerosis (Rrms)

Posted Date: May 15, 2019

Consonance MN39159

-Have A Definite Diagnosis Of Rrms, As Per The Revised Mcdonald 2010 Criteria -Have A Length Of Dis

Ocrelizumab , Relapsing Remitting

Molly Winters
513-558-0269
molly.winters@uc.edu

Name*
First Last
Gender*
- Male
- Female
Age*
Phone*
Email*
How did you hear about us?*
Future Communication*
- By submitting this form, I am agreeing to receive future communication about participating in an upcoming research study.
CAPTCHA
This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
For questions regarding clinical studies at UC Health, contact us at ResearchStudies@UCHealth.com or (513) 245-3417.
List